Jamie Perse
Stock Analyst at Goldman Sachs
(3.13)
# 1,254
Out of 5,032 analysts
67
Total ratings
54.76%
Success rate
11.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jamie Perse
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGL agilon health | Maintains: Neutral | $2.5 → $5 | $0.96 | +420.89% | 7 | May 8, 2025 | |
| THC Tenet Healthcare | Maintains: Neutral | $134 → $154 | $200.00 | -23.00% | 12 | May 5, 2025 | |
| LFST LifeStance Health Group | Upgrades: Buy | $10 | $5.03 | +98.81% | 7 | Dec 16, 2024 | |
| OPCH Option Care Health | Downgrades: Neutral | $38 → $27 | $27.77 | -2.77% | 3 | Nov 5, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $32 | $19.92 | +60.64% | 1 | Aug 19, 2024 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $21 → $18 | $29.73 | -39.46% | 3 | Aug 9, 2024 | |
| UHS Universal Health Services | Maintains: Buy | $200 → $229 | $204.56 | +11.95% | 16 | Jul 30, 2024 | |
| INNV InnovAge Holding | Maintains: Neutral | $8 → $7 | $5.34 | +31.21% | 5 | Feb 8, 2024 | |
| HCA HCA Healthcare | Downgrades: Neutral | n/a | $426.16 | - | 10 | Dec 11, 2023 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $13 | $8.06 | +61.29% | 2 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $25.53 | +25.34% | 1 | Feb 3, 2023 |
agilon health
May 8, 2025
Maintains: Neutral
Price Target: $2.5 → $5
Current: $0.96
Upside: +420.89%
Tenet Healthcare
May 5, 2025
Maintains: Neutral
Price Target: $134 → $154
Current: $200.00
Upside: -23.00%
LifeStance Health Group
Dec 16, 2024
Upgrades: Buy
Price Target: $10
Current: $5.03
Upside: +98.81%
Option Care Health
Nov 5, 2024
Downgrades: Neutral
Price Target: $38 → $27
Current: $27.77
Upside: -2.77%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $32
Current: $19.92
Upside: +60.64%
BrightSpring Health Services
Aug 9, 2024
Maintains: Buy
Price Target: $21 → $18
Current: $29.73
Upside: -39.46%
Universal Health Services
Jul 30, 2024
Maintains: Buy
Price Target: $200 → $229
Current: $204.56
Upside: +11.95%
InnovAge Holding
Feb 8, 2024
Maintains: Neutral
Price Target: $8 → $7
Current: $5.34
Upside: +31.21%
HCA Healthcare
Dec 11, 2023
Downgrades: Neutral
Price Target: n/a
Current: $426.16
Upside: -
Enhabit
Jul 17, 2023
Maintains: Neutral
Price Target: $15 → $13
Current: $8.06
Upside: +61.29%
Feb 3, 2023
Initiates: Buy
Price Target: $32
Current: $25.53
Upside: +25.34%